Email Updates

You are here

AVAC's Blog: P-Values

  • Last month, AVAC released our annual, opinionated state-of-the-field report—Mixed Messages and How to Untangle Them. It’s filled with information, graphics and in-depth analysis and definitely worth a read! This month, we’re also pleased to offer highlights of the report in the December episode of our podcast Px Pulse, which is now up. Find it on iTunes or click here for Px Pulse on avac.org.

    December 19, 2017
    General
    AVAC
  • Across Africa advocates are increasing their organizational power in new networks and collaborative partnerships. Read this blog from Morenike Oluwatoyin Folayan of the New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) to get the details on the new platforms shaping the agenda for HIV prevention advocacy from Cote d’Ivoire to South Africa.

    December 11, 2017
    HIV Vaccine, General, PrEP
    Morenike Oluwatoyin Folayan
  • In November, the South African Medical Research Council held a summit to discuss standard of care in prevention and treatment trials in Southern Africa. Standard of care has been discussed and debated for nearly as long as the research itself. What’s new is stakeholders across prevention research coming together to reach consensus on not only the package but on how it should be delivered.

    December 7, 2017
    AVAC
  • This letter comes from a group of young African women and reflects their HIV prevention research priorities. It was submitted to the National Institutes of Health’s (NIH) Division of AIDS (DAIDS) during the open-comment period concerning the structure and agenda for its next funding cycle (2021-2027).

    December 6, 2017
    Eight Young Women from South Africa, Uganda and Zimbabwe
  • AVAC is pleased to share a new series of videos on the introduction of daily oral PrEP in Kenya—Lessons from the Field. The series features lessons on how to fit this newer prevention option into the lives of people who need it through case studies of issues related to supporting Kenyan women who choose to take daily oral PrEP.

    December 5, 2017
    AVAC
  • On the eve of World AIDS Day, AVAC is excited to share our annual “state of the field” report on biomedical prevention research and implementation. AVAC Report 2017: Mixed Messages and How to Untangle Them is straight talk about today’s complex context for HIV prevention.

    November 30, 2017
    General
    AVAC
  • Just ahead of another World AIDS Day, two new efficacy trials officially launched in Africa today with the potential of additional HIV prevention methods in the future.

    November 30, 2017
    AVAC
  • ICASA 2017 is coming right up, and AVAC will be there along with many of our partners participating in sessions both before and during the conference. There are several ways you can link to HIV prevention research and rollout-related events—both in-person and from afar.

    November 29, 2017
    General
    AVAC
  • We are excited to share with you our new episode of Px Pulse, AVAC’s podcast covering vital topics in HIV prevention research. This month, we look at the standard of care in HIV prevention trials in the era of oral PrEP. This issue has been discussed and hotly debated lately—and for good reason: It’s complicated.

    November 27, 2017
    AVAC
  • AVAC’s newest issue of Px Wire is coming to you at a critical moment. We’re sharing our recommendations to the US National Institutes of Health’s Division of AIDS (DAIDS), which is in the final days of accepting comments before it begins the process of restructuring the clinical trials networks responsible for a large share of the world’s HIV research.

    November 22, 2017
    General
    AVAC

Pages